{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:07:48Z","timestamp":1776103668827,"version":"3.50.1"},"reference-count":57,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.32072","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T16:30:41Z","timestamp":1610728241000},"page":"e2032072","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of Aspirin Use With Cancer Incidence and Survival Among Older Adults in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial"],"prefix":"10.1001","volume":"4","author":[{"given":"Holli A.","family":"Loomans-Kropp","sequence":"first","affiliation":[{"name":"Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland"},{"name":"Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Pinsky","sequence":"additional","affiliation":[{"name":"Early Detection Research Branch, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Umar","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"issue":"12","key":"zoi200992r1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"key":"zoi200992r3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pmedr.2016.12.023","article-title":"Recent trends in the prevalence of low-dose aspirin use for primary and secondary prevention of cardiovascular disease in the United States, 2012-2015.","volume":"5","author":"Stuntz","year":"2016","journal-title":"Prev Med Rep"},{"issue":"1","key":"zoi200992r4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population.","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann Oncol"},{"issue":"6","key":"zoi200992r5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","article-title":"Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.","volume":"150","author":"US Preventive Services Task Force","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi200992r6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis.","volume":"321","author":"Zheng","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"zoi200992r7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","article-title":"Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.","volume":"10","author":"Cuzick","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9573","key":"zoi200992r8","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"issue":"16","key":"zoi200992r9","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly.","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"zoi200992r10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djaa114","article-title":"Effect of aspirin on cancer incidence and mortality in older adults.","author":"McNeil","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"9826","key":"zoi200992r11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"issue":"9754","key":"zoi200992r12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"zoi200992r13","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett\u2019s oesophagus: a prospective study.","volume":"6","author":"Vaughan","year":"2005","journal-title":"Lancet Oncol"},{"issue":"6","key":"zoi200992r14","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1053\/j.gastro.2011.08.036","article-title":"Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett\u2019s esophagus.","volume":"141","author":"Kastelein","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"zoi200992r15","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s10620-018-5149-6","article-title":"Chemoprevention of Barrett\u2019s esophagus and esophageal adenocarcinoma.","volume":"63","author":"Bresalier","year":"2018","journal-title":"Dig Dis Sci"},{"issue":"10","key":"zoi200992r16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/S1542-3565(04)00389-1","article-title":"Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence.","volume":"2","author":"Bardou","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"zoi200992r17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ijc.v145.1","article-title":"Long-term use of low-dose aspirin for cancer prevention: a 10-year population cohort study in Hong Kong.","volume":"145","author":"Tsoi","year":"2019","journal-title":"Int J Cancer"},{"issue":"6","key":"zoi200992r18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ejso.2015.02.006","article-title":"Regular aspirin use and stomach cancer risk in China.","volume":"41","author":"Wang","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"zoi200992r19","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1089\/jwh.2016.6040","article-title":"Low-dose aspirin reduces breast cancer risk in women with diabetes: a nationwide retrospective cohort study in Taiwan.","volume":"26","author":"Yang","year":"2017","journal-title":"J Womens Health (Larchmt)"},{"issue":"5","key":"zoi200992r20","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1053\/j.gastro.2017.12.001","article-title":"Regular use of aspirin or non-aspirin nonsteroidal anti-inflammatory drugs is not associated with risk of incident pancreatic cancer in two large cohort studies.","volume":"154","author":"Khalaf","year":"2018","journal-title":"Gastroenterology"},{"issue":"12","key":"zoi200992r21","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10552-016-0824-4","article-title":"Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study.","volume":"27","author":"Kho","year":"2016","journal-title":"Cancer Causes Control"},{"issue":"1","key":"zoi200992r22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/1055-9965.EPI-16-0508","article-title":"Aspirin use and reduced risk of pancreatic cancer.","volume":"26","author":"Risch","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"zoi200992r23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1525-1438.2007.00867.x","article-title":"Exploring the potential chemopreventative effect of aspirin and rofecoxib on hereditary nonpolyposis colorectal cancer-like endometrial cancer cells in vitro through mechanisms involving apoptosis, the cell cycle, and mismatch repair gene expression.","volume":"17","author":"Wood","year":"2007","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"zoi200992r24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.2014.271","article-title":"Molecular targets of aspirin and cancer prevention.","volume":"111","author":"Alfonso","year":"2014","journal-title":"Br J Cancer"},{"issue":"1-2","key":"zoi200992r25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity.","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"issue":"1","key":"zoi200992r26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"issue":"6","key":"zoi200992r27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1158\/0008-5472.CAN-16-2490","article-title":"Systematic pan-cancer analysis reveals immune cell interactions in the tumor microenvironment.","volume":"77","author":"Varn","year":"2017","journal-title":"Cancer Res"},{"issue":"3","key":"zoi200992r28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000341498","article-title":"Barrett\u2019s to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer.","volume":"29","author":"Picardo","year":"2012","journal-title":"Dig Surg"},{"issue":"4","key":"zoi200992r29","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer.","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"9","key":"zoi200992r30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","article-title":"Aspirin intake and survival after breast cancer.","volume":"28","author":"Holmes","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5B","key":"zoi200992r31","first-page":"3177","article-title":"Aspirin use and mortality from cancer in a prospective cohort study.","volume":"24","author":"Ratnasinghe","year":"2004","journal-title":"Anticancer Res"},{"issue":"1","key":"zoi200992r32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/EDE.0000000000000746","article-title":"Aspirin use and mortality in two contemporary US cohorts.","volume":"29","author":"Huang","year":"2018","journal-title":"Epidemiology"},{"issue":"12","key":"zoi200992r33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16729","article-title":"Association of aspirin use with mortality risk among older adult participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.","volume":"2","author":"Loomans-Kropp","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi200992r34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/bjc.2012.227","article-title":"Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.","volume":"107","author":"Shebl","year":"2012","journal-title":"Br J Cancer"},{"issue":"7","key":"zoi200992r35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/1940-6207.CAPR-17-0033","article-title":"Do aspirin and other NSAIDs confer a survival benefit in men diagnosed with prostate cancer? a pooled analysis of NIH-AARP and PLCO cohorts.","volume":"10","author":"Zhou","year":"2017","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"zoi200992r36","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ygyno.2020.08.038","article-title":"Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening Trial.","volume":"159","author":"Hurwitz","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"12","key":"zoi200992r37","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1038\/ajg.2010.349","article-title":"Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.","volume":"105","author":"Johnson","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"13","key":"zoi200992r38","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1056\/NEJMoa0810696","article-title":"Mortality results from a randomized prostate-cancer screening trial.","volume":"360","author":"Andriole","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi200992r39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jnci\/djr500","article-title":"Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.","volume":"104","author":"Andriole","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"zoi200992r40","doi-asserted-by":"publisher","first-page":"273S","DOI":"10.1016\/S0197-2456(00)00098-2","article-title":"Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.","volume":"21","author":"Prorok","year":"2000","journal-title":"Control Clin Trials"},{"issue":"1","key":"zoi200992r44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12963-017-0142-4","article-title":"Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study.","volume":"15","author":"Withrow","year":"2017","journal-title":"Popul Health Metr"},{"issue":"8","key":"zoi200992r45","first-page":"342","article-title":"Bayesian analysis of esophageal cancer mortality in the presence of misclassification.","volume":"9","author":"Pourhoseingholi","year":"2011","journal-title":"Italian J Public Health"},{"issue":"5","key":"zoi200992r46","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.juro.2018.05.119","article-title":"The association of aspirin use with survival following radical cystectomy.","volume":"200","author":"Lyon","year":"2018","journal-title":"J Urol"},{"issue":"12","key":"zoi200992r47","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/carcin\/20.12.2305","article-title":"Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.","volume":"20","author":"Kitayama","year":"1999","journal-title":"Carcinogenesis"},{"key":"zoi200992r48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.anndiagpath.2018.01.008","article-title":"Overexpression of COX2 indicates poor survival in urothelial bladder cancer.","volume":"34","author":"Agrawal","year":"2018","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"zoi200992r49","first-page":"385","article-title":"High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer.","volume":"27","author":"Wild","year":"2005","journal-title":"Int J Oncol"},{"issue":"4 Pt 1","key":"zoi200992r50","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1097\/00005392-200210010-00086","article-title":"Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer.","volume":"168","author":"Wheeler","year":"2002","journal-title":"J Urol"},{"issue":"49","key":"zoi200992r51","doi-asserted-by":"publisher","first-page":"13030","DOI":"10.1073\/pnas.1709119114","article-title":"Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.","volume":"114","author":"Basudhar","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"zoi200992r52","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/jcp.55.6.429","article-title":"Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.","volume":"55","author":"Costa","year":"2002","journal-title":"J Clin Pathol"},{"issue":"1","key":"zoi200992r53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer.","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"issue":"6","key":"zoi200992r54","first-page":"545","article-title":"Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention.","volume":"9","author":"Li","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"zoi200992r55","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1053\/j.gastro.2017.10.044","article-title":"Low-dose aspirin use does not increase survival in 2 independent population-based cohorts of patients with esophageal or gastric cancer.","volume":"154","author":"Spence","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"zoi200992r56","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/j.1572-0241.2002.05528.x","article-title":"NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.","volume":"97","author":"Husain","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"zoi200992r57","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"key":"zoi200992r2","unstructured":"Soni? A. Aspirin use among the adult U.S. noninstitutionalized population, with and without indicators of heart disease, 2005. Medical Expenditure Panel Survey; Agency for Healthcare Research and Quality. Published July 2007. Accessed December 2, 2020. https:\/\/meps.ahrq.gov\/data_files\/publications\/st179\/stat179.pdf"},{"key":"zoi200992r41","unstructured":"National Cancer Institute. PLCO. Accessed December 2, 2020. https:\/\/cdas.cancer.gov\/plco\/"},{"key":"zoi200992r42","unstructured":"National Cancer Institute. Baseline questionnaire (BQ) datasets. Accessed March 20, 2020. https:\/\/biometry.nci.nih.gov\/cdas\/datasets\/plco\/90\/"},{"key":"zoi200992r43","unstructured":"National Cancer Institute. The supplemental questionnaire (SQX) datasets. Accessed March 20, 2020. https:\/\/biometry.nci.nih.gov\/cdas\/datasets\/plco\/91\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2775219\/loomanskropp_2021_oi_200992_1610549596.36072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T16:31:04Z","timestamp":1610728264000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2775219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.32072","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}